The Trump administration’s claim that its TrumpRx website offers the “world’s lowest prices” on prescription drugs does not hold up against international comparisons, according to a March 18 review by The New York Times and German media partners. TrumpRx launched…
Pharmacy
The Kentucky Board of Pharmacy has taken disciplinary actions against Med Save Pharmacy in Eminence, Ky., and its pharmacist-in-charge, Drane Stephens, following a series of compounding errors that hospitalized three pediatric patients. The board launched an investigation Aug. 26, 2024,…
The top 15 U.S. pharmacies accounted for nearly 75% of the nation’s $751 billion of prescription dispensing revenue in 2025, according to Drug Channels. CVS Health led all dispensing organizations with $119 billion in revenue, followed by Walgreens at $90.8…
The FDA has rejected Aldeyra Therapeutics’ application for reproxalap, an investigational treatment for dry eye disease, citing a lack of substantial evidence that the drug is effective. In a Complete Response Letter, the agency said inconsistent study results raised concerns…
When 94% of providers report care delays tied to prior authorization requirements (AMA), specialty pharmacy leaders face a defining question: how do you scale without losing high-quality patient care and the human touch? For Shields Health Solutions, which integrates specialty…
Advertisement
The FDA has cleared GSK’s respiratory syncytial virus vaccine for use in adults ages 18 to 49 who are at increased risk for severe disease. The vaccine, Arexvy, was originally approved in 2023 for use in adults 60 and older.…
A former pharmacy leader at Louisville, Ky.-based Baptist Health System, Jordan Propst, PharmD, has joined Greenville, S.C.-based Prisma Health. Dr. Propst announced the transition in a March 16 LinkedIn post, saying he is joining Prisma Health as pharmacy director of…
Clinicians are divided amid a growing demand for an unproven autism drug and wanting to preserve their patient-physician relationships, NPR reported March 16. Last fall, a federal press conference touted a new, unproven, treatment for autism: leucovorin. This derivative of…
Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on manufacturing in India. India supplies roughly 47% of all generic…
Medicaid spending on outpatient prescription drugs has climbed sharply in recent years even as utilization remained relatively flat and enrollment declined. A March 12 report from KFF outlines the key drivers of the increase and the early impact of new…